Clinical Trial: To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy.

Brief Summary: To evaluate the long-term safety of pregabalin in refractory partial epilepsy.

Detailed Summary:
Sponsor: Pfizer

Current Primary Outcome: Safety

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Pfizer

Dates:
Date Received: August 30, 2005
Date Started: November 1997
Date Completion: October 2005
Last Updated: December 28, 2006
Last Verified: December 2006